WINT - WINDTREE THERAPEUTICS INC /DE/
0.137
0.027 19.708%
Share volume: 6,696,079
Last Updated: 08-21-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$0.11
0.03
0.25%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-26-2024 | 05-15-2025 | 08-19-2025 | 11-19-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 4.405 M | 11.452 M | 4.741 M | 4.090 M | 3.984 M | 3.752 M | |
| Selling general and admin | 2.152 M | 1.589 M | 2.773 M | 1.820 M | 1.802 M | 1.855 M | |
| Research and development | 2.253 M | 9.863 M | 1.968 M | 2.270 M | 2.182 M | 1.897 M | |
| Total expenses | 4.405 M | 11.452 M | 4.741 M | 4.090 M | 3.984 M | 19.882 M | |
| 159.98% | -58.60% | -13.73% | -2.59% | 399.05% | |||
| Operating income | -4.405 M | -11.452 M | -4.741 M | -4.090 M | -3.984 M | -19.882 M | |
| Ebit | -4.204 M | -11.737 M | -3.021 M | -4.010 M | -3.511 M | -16.981 M | |
| Pretax income | 10.333 M | -11.827 M | -2.989 M | -4.045 M | -10.631 M | -31.516 M | |
| -214.46% | -74.73% | 35.33% | 162.82% | 196.45% | |||
| Income tax | 114.000 K | 197.000 K | -240.000 K | 0.000 | 0.000 | -3.431 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 10.219 M | -12.024 M | -2.749 M | -4.045 M | -10.631 M | -28.085 M | |
| -217.66% | 77.14% | -47.14% | -162.82% | -164.18% |